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Opioid agonists are the best therapy for moderate to severe pain, but clinical use is limited due to the development of tolerance
and dependence. For the first time, Bailey and co-workers have demonstrated functional selectivity for agonist-induced
desensitization of m-opioid receptors (MOR) in mature rat locus coeruleus neurons. Native MORs are differentially desensitized
through separate, agonist-dependent signalling pathways; desensitization of the morphine-occupied receptor occurs via a
protein kinase C alpha-dependent pathway while [D-Ala2, N-MePhe4, Gly-ol]enkephalin-mediated desensitization is via a G
protein receptor kinase subtype 2-dependent mechanism. These results suggest that MORs adopt separate conformational
states that either result in different efficiencies of G protein activation or access to phosphorylation by desensitization machinery
(e.g. protein kinase C alpha or G protein receptor kinase subtype 2). Further study of the interaction of protein kinase C with
MORs in native neurons will enhance our understanding of agonist-induced functional selectivity for desensitization at MORs
and provide important insights into how to selectively modulate agonist efficacy to enhance therapeutic capabilities of
opioid drugs.
British Journal of Pharmacology (2009) 158, 154–156; doi:10.1111/j.1476-5381.2009.00198.x
This article is a commentary on Bailey et al., pp. 157–164 of this issue and is part of a themed issue on GPCR. To
view this issue visit http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009
Keywords: morphine; m-opioid receptor; PKC; opioid; opiate; desensitization; tolerance; G protein-coupled receptor kinase
(GRK); DAMGO; G protein
Abbreviations: DAMGO, [D-Ala2, N-MePhe4, Gly-ol]enkephalin; GIRK, G protein coupled inwardly rectifying potassium
channel; GPCR, G protein-coupled receptor; GRK2, G protein receptor kinase subtype 2; LC, locus coeruleus;
MOR, m-opioid receptor; PKCa, protein kinase C alpha
Agonists of the m-opioid receptor (MOR) are the most appro-
priate therapy for moderate to severe pain, although issues of
the development of tolerance and dependence diminish their
usefulness in patients requiring chronic treatment. Much
work has been done to elucidate the cellular mechanisms of
opioid-induced analgesia, tolerance and dependence in the
hope of finding an analgesic that is capable of enhancing pain
relief without initiating the cellular processes involved in
tolerance and dependence. Current work on G protein-
coupled receptors (GPCRs), of which opioid receptors are one
family, have demonstrated that different agonists are capable
of ’functional selectivity’, that is, initiating ligand-dependent
conformational states that result in differential signalling
mechanisms (Urban et al., 2007). The data presented in this
issue of the British Journal of Pharmacology by Bailey et al.
(2009) provide evidence for functional selectivity of agonist-
induced desensitization of MORs in mature rat locus coer-
uleus (LC) neurons. This work is particularly significant in
that, for the first time, native MORs in mature neurons are
shown to be differentially desensitized through separate,
agonist-dependent signalling pathways.
Bailey et al. (2009) show that acute morphine-induced
desensitization is mediated through protein kinase C (PKC)a
in mature LC neurons while [D-Ala2, N-MePhe4, Gly-
ol]enkephalin (DAMGO)-induced desensitization occurs via
the more traditional and accepted G protein receptor kinase
Correspondence: John Traynor, Department of Pharmacology, University of
Michigan Medical School, 1301 MSRB III, 1150 W. Medical Center Drive,
University of Michigan, Ann Arbor, MI 48109-0632, USA. Email: jtraynor@
mich.edu
Received 06 January 2009; revised 14 January 2009; accepted 15 January 2009
British Journal of Pharmacology (2009), 158, 154–156
Journal compilation © 2009 The British Pharmacological Society
No claim to original US government works All rights reserved 0007-1188/09
www.brjpharmacol.org
(GRK) subtype 2 (GRK2)-dependent mechanism. GRK2 is
recruited to the membrane by Gbg subunits released following
activation of heterotrimeric G proteins by agonist-occupied
receptors. Both morphine and DAMGO cause activation of G
proteins and show no marked differences in the types of Ga
proteins with which they interact (Clark et al., 2006). They
also exhibit the same qualitative signalling responses,
although the potency and efficacy for DAMGO is generally
higher. This may be important because activation of Gbg is a
very early event following receptor occupancy and so requires
considerably more agonist efficacy than events further down-
stream. Morphine is a low-efficacy agonist at the level of G
protein and may be insufficiently efficacious to recruit GRK2
to effectively phosphorylate the receptor. The fact that the
binding domain on Gbg for GRK2 overlaps considerably with
the binding sites for other Gbg effectors, including PLCb and
ion channels, so that these proteins compete with GRK2 for
binding to Gbg (Lodowski et al., 2003) emphasizes the low
level of activation of Gbg by morphine. This may explain why
increasing the level of GRK2 in a cell does result in GRK2-
mediated internalization of MOR (see Connor et al., 2004).
Further support for this idea comes from observations that
Gbg does have differential ability to activate effectors as seen,
for example, when comparing MOR activation of membrane
delimited Gbg coupling to ion channels in LC neurons. MOR
activation of G protein coupled, inwardly rectifying, potas-
sium channels (GIRK) and Ca2+ channels, via lateral diffusion
of released Gbg subunits, are the fastest measures of MOR
coupling in neurons (Connor et al., 2004). Although the effi-
cacy of morphine to stimulate GIRK and inhibit Ca2+ channels
is lower than that of DAMGO, morphine is more effective at
inhibiting Ca2+ channels than activating GIRK channels in
isolated LC neurons (Ingram et al., 1997). These results more-
over suggest that functional differences in efficacy are medi-
ated, in part, via mechanisms downstream of the MOR, at
least with acute administration of agonists. Many studies
have demonstrated that significant changes occur in MOR
regulation after chronic administration of opioids (see
Christie, 2008).
An alternative explanation for the failure of morphine to
promote GRK-mediated phosphorylation of MOR is that GRK
recruitment by the Gbg subunits does occur, but that the GRK
is unable to phosphorylate the morphine-occupied MOR. Fol-
lowing recruitment to the plasma membrane, GRK2 is ori-
ented to facilitate phosphorylation of activated GPCRs.
However, the activated GPCR alters the conformation of the
GRK such that the kinase is activated (Singh et al., 2008).
Thus, the morphine-occupied MOR may not be phosphory-
lated because it is not in a conformation, or set of conforma-
tions, which allows for activation of the kinase activity of
GRK2 and/or for phosphorylation by GRK2.
The hypothesis that agonists acting at the same GPCR show
functional selectivity for different signalling pathways, based
on agonist-specific receptor conformations and/or differential
strength of signalling dependent on agonist efficacy, has
become popular over the past decade (see Connor et al., 2004;
Urban et al., 2007). The plethora of agonists for, and interest
in, signalling pathways of MORs has helped shape the
concept of functional selectivity and the prototypical full and
partial agonists, DAMGO and morphine, respectively, have
been used extensively to explore MOR signalling (see Connor
et al., 2004; Christie, 2008). These studies demonstrate that
there are differences in agonist profiles for antinociception,
GIRK activation, mitogen-activated protein kinase activation,
adenylyl cyclase inhibition, desensitization and internaliza-
tion. However, the case for physiological functional selectiv-
ity of agonist-induced MOR signalling has not yet been made
and the question remains as to whether differences in agonist-
induced MOR signalling are the result of physiologically rel-
evant agonist-specific conformational states of MORs, the
particular subset of signalling proteins and their regulators,
the presence of the receptor in certain membrane micro-
domains or a combination of the above. One major difficulty
in comparing studies is the conditions under which each
study is performed, including heterologous versus endog-
enous expression, expression levels of receptors and modula-
tors, effector-coupling mechanisms studied and different cell
types, species and duration of drug treatments (acute vs.
chronic).
The issues associated with defining functional selectivity
underscore the need to study receptor interactions in native
tissues with endogenous levels of receptors while paying close
attention to the temporal resolution of receptor–effector cou-
pling. Bailey et al. (2009) demonstrate that morphine-induced
desensitization of MORs in mature LC neurons is minimal
in vitro in the absence of PKC stimulation by either phorbol
esters or via concomitant stimulation of PKC by M3 muscar-
inic receptors. Consequently, it does not appear that mor-
phine binding to the MOR activates PKC activity in LC
neurons, although morphine occupancy of MOR is needed for
effective desensitization. Therefore, the observed agonist-
induced functional selectivity for desensitization does not
look to be a result of differential activation of effector systems
(GRK vs. PKC), but rather that PKC recognizes a MOR confor-
mation(s) that may be specific to morphine compared with
DAMGO occupation of the binding site, although it has not
been ruled out that PKCa could play a role in desensitization
of the DAMGO-occupied MOR in the absence of GRK2 activ-
ity. Certainly in analysing the findings of Bailey et al. (2009),
it should be noted that the insensitivity of morphine to GRK2
is not absolute. For example, in cultured rat striatal neurons
morphine induces rapid endocytosis of MOR (Haberstock-
Debic et al., 2005) and in heterologous systems with GRK2
overexpression, morphine alone can cause internalization of
MOR following GRK2-mediated phosphorylation (see Connor
et al., 2004). Thus, it is likely that the morphine-occupied
MOR does directly recruit GRK and undergoes receptor phos-
phorylation, for example, in cells expressing higher G protein
or GRK levels or in cells in which negative regulators of G
protein signalling that allow for the rapid recombination of
Ga and Gbg subunits are low or ineffective. Under these
conditions, levels of released Gbg subunits are increased
(Clark et al., 2003) and may recruit sufficient GRK2 for
phosphorylation of the morphine-occupied MOR.
The data presented by Bailey et al. (2009) provide evidence
that PKC, activated by a MOR-independent mechanism, may
potentially recognize a morphine-specific conformation of
MOR and so cause receptor desensitization. What, then,
are the implications of this alternative desensitization
mechanism? Desensitization of the receptor, followed by
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re-sensitization, is vital for the cell to prevent continual bom-
bardment by neurotransmitter signals and be in a position to
respond to new incoming signals. Thus, the cell provides
more than one pathway to achieve this, including the PKCa-
mediated desensitization mechanism, which functions for
agonists that do not efficiently initiate homologous, GRK-
mediated, desensitization. Further study of the interaction of
PKC with MORs in native neurons will enhance our under-
standing of the complex regulation associated with agonist
activation of MORs. Certainly, the in vivo observations that
PKC inhibitors can reduce morphine anti-nociceptive toler-
ance (Smith et al., 2007) provide evidence that selective
inhibition of those PKCs involved, or pharmacological inter-
vention at Gaq-linked receptors co-expressed in similar loca-
tions to MORs within target neurons, might provide useful
adjuncts to chronic therapy with opioid drugs.
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